This quick video takes a look at Mylan (MYL) ahead of its earnings report. The pharma company has been under pressure for much of 2016 while a bottom 33% industry rank isn’t helping matters either. Even more troubling than the weak …
Mylan's stock is down over 30% in 2016, making it more attractively valued than it's been in a long time. While all of the attention this year has been about EpiPen, the reality is that the product will probably account for only 6% of Mylan's …
Stringer manages about $163 billion in pension funds for the city, including 1,059,357 shares of Mylan common stock worth about $45 million, he said. “Mylan’s gross mismanagement of its EpiPen pricing strategy exacerbates the …
(Reuters) - Shares of Mylan soared 12 percent in heavy premarket trading. The drugmaker on Friday said it would pay $465 million to settle questions over whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen …
There's no justification for these price hike", the drug pricing issue will remain in focus (Read more: Did Hillary Clinton's Tweet Cause the Sell-Off in Mylan Stock?). Novartis Scores Another Win in Biosimilar Segment: Novartis scored …
Mylan CEO Heather Bresch listens to an aide during a hearing before lying to the House Oversight and Government Reform Committee on September 21, 2016 (Photo by Alex Wong/Getty Images) Mylan, the drug company that makes EpiPen, …
SACRAMENTO, Calif. — Gov. Jerry Brown has approved legislation that allows businesses to stock EpiPens, which are used to treat people having life-threatening allergic reactions. The Democratic governor signed AB1386 Thursday. He …
Pharma giant Mylan has agreed to pay the federal government $465 million to settle questions of how the company’s EpiPen was classified under the Medicaid Drug Rebate Program. Mylan announced the deal late on Friday afternoon. …
Mylan N.V. MYL is scheduled to report first-quarter 2017 results on May 10, before the market opens. The company’s performance has been mixed so far, having beaten earnings estimates in three of the trailing four quarters and missing …